Sage Journals: Discover world-class research

Retricted access

Research article

First published 2014-3

Reverse-Payment Patent Settlements in the Pharmaceutical Industry: An Analysis of U.S. Antitrust Law and EU Competition Law

Michael Clancy, Damien Geradin, Andrew Lazerow

The Antitrust Bulletin

Retricted access

Research article

First published 2018-6

The Role of Risk Aversion in Reverse Payment Agreements

Wenqing Li

The Antitrust Bulletin

Retricted access

Research article

First published 2018-7

Pay for Delay Agreements: Antitrust Watch Intensifies

Twinkle Chawla, Ruchi Verma

Journal of National Law University Delhi

Retricted access

Research article

First published 2013-3

Supreme court to resolve legality of ‘reverse payment’ settlement agreements between brand-name drug manufacturers and generic competitors

Jill M Browning

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2024-08

The Localization of Drug Patent Linkage System in China: Where Should It Go?

Heng Hu, Guoyue Hou

Biotechnology Law Report

Retricted access

Research article

First published 2013-3

Taking Antitrust to Patent School: The Instance of Pay-For-Delay Settlements

Rudolph J.R. Peritz

The Antitrust Bulletin

Retricted access

Research article

First published 2012-9

Delay in generic entry should remain a concern to competition authorities

Paul Csiszár

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Retricted access

Research article

First published 2026-3

The dual barriers to biosimilar competition: A comparative analysis of US patent thickets and EU supplementary protection certificates

Raviraj Kadam

Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector

Search results